Lexicon Pharmaceuticals Inc Cash Flow Reinvestment Rate
Lexicon Pharmaceuticals Inc cash flow reinvestment rate. Lexicon Pharmaceuticals Inc (LXRX) has a Cash Flow Reinvestment Rate of 0.91x as of June 2025, reinvesting $15.48 Million (capex $0.00 plus investments $15.48 Million) from operating cash flow of $16.99 Million. Explore LXRX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Lexicon Pharmaceuticals Inc (2005–2019)
Cash flow reinvestment rate of Lexicon Pharmaceuticals Inc from 2005 to 2019. Historical reinvestment intensity for Lexicon Pharmaceuticals Inc across 3 annual periods. Explore how much does Lexicon Pharmaceuticals Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Lexicon Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2005–2019)
Lexicon Pharmaceuticals Inc cash flow reinvestment rate by year from 2005 to 2019. Year-by-year capital reinvestment analysis for Lexicon Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Lexicon Pharmaceuticals Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 1.37x | $155.85 Million | $113.81 Million | $70.00K | ▲ +115.6% |
| 2015 | 0.64x | $117.36 Million | $184.78 Million | $910.00K | ▲ +32.0% |
| 2005 | 0.48x | $11.28 Million | $23.44 Million | $11.28 Million | — |